Fever News and Research

RSS

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Malaria is an infection caused by a parasite called plasmodium, which is transmitted from person to person by females of some species of mosquito. It is primarily a disease of tropical countries.

14 Dec 2012

Study investigates different approaches to eradicate mosquito-borne diseases

A special issue of Pathogens and Global Health, published by Maney Publishing, investigates different approaches to eradicate mosquito-borne diseases. Mosquitoes can transmit a number of pathogenic diseases including dengue fever, yellow fever, and malaria.

13 Dec 2012

Inotuzumab ozogamicin selectively destroys malignant cells responsible for ALL in weekly dosing

A potent chemotherapy agent wrapped within a monoclonal antibody selectively destroys the malignant cells responsible for acute lymphocytic leukemia (ALL) in either weekly or monthly dosing, researchers report at the 54th ASH Annual Meeting and Exposition.

12 Dec 2012

U.N. officials call on Security Council, international community to tackle complex crisis in Sahel

"Top United Nations officials on Monday called on the Security Council and the wider international community to support efforts to develop an integrated strategy to tackle the complex and multifaceted crisis facing the Sahel region of West Africa," the U.N. News Centre reports.

12 Dec 2012

Researchers shed new light on how salmonella bacteria cause infections

Researchers have found that the bacteria are able to change key cells that line the intestine, enabling the bugs to thrive.

12 Dec 2012

Top-line results from Durata Therapeutics’ dalbavancin Phase 3 study on ABSSSI

Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).

11 Dec 2012

Quizartinib shows promise against acute myeloid leukemia in Phase II trial

A new drug for patients with acute myeloid leukemia (AML) marked by a specific type of genetic mutation has shown surprising promise in a Phase II clinical trial.

11 Dec 2012

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

Celgene International Sàrl today announced that results from a study evaluating the combination of REVLIMID (lenalidomide) plus VIDAZA (azacitidine) in patients 60 years or older with untreated acute myeloid leukemia (AML) were presented at the American Society of Hematology annual meeting in Atlanta, GA.

11 Dec 2012

New hope for leukemia patients

Nine of twelve leukemia patients who received infusions of their own T cells after the cells had been genetically engineered to attack the patients' tumors responded to the therapy, which was pioneered by scientists in the Perelman School of Medicine at the University of Pennsylvania

10 Dec 2012

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Genentech, a member of the Roche Group, today announced updated survival results from the Phase III CLEOPATRA study, which showed that the combination of Perjeta (pertuzumab), Herceptin (trastuzumab) and docetaxel chemotherapy significantly extended the lives (overall survival) of people with previously untreated HER2-positive metastatic breast cancer (mBC), compared to Herceptin, chemotherapy and placebo.

10 Dec 2012

Sanofi Pasteur’s IMOJEV vaccine against Japanese encephalitis is now available in Australia

Sanofi Pasteur, the vaccines division of Sanofi, announced today that IMOJEV vaccine against Japanese encephalitis (JE) is now available in Australia.

10 Dec 2012

Results of Halaven Phase III study in metastatic breast cancer presented at 2012 CTRC-AACR SABCS

Results from the first large, global Phase III study of Halaven (eribulin mesylate) Injection in patients with early-stage metastatic breast cancer were presented today during the 2012 CTRC-AACR San Antonio Breast Cancer Symposium.

7 Dec 2012

Prosthetic joint infection guidelines released

The Infectious Diseases Society of American has released guidelines for the diagnosis and care of patients with a prosthetic joint infection.

7 Dec 2012

Pesticides in tap water may increase food allergy risk

Having a high level of urinary dichlorophenols is associated with the presence of food sensitization and allergies, say researchers.

7 Dec 2012

WHO assists Middle East authorities with coronavirus investigation

The World Health Organization has sent a team to Jordan at the request of the country’s Ministry of Health to help investigate the emergence of a novel coronavirus that resulted in the deaths of two people earlier this year, and to assist with further epidemiologic surveillance.

5 Dec 2012

Yellow Fever kills 164 in Sudan's Darfur; Agencies working to vaccinate people in region

"Yellow fever has killed 164 people over the last three months in Sudan's Darfur, the World Health Organization (WHO) said on Monday," Reuters reports. According to a joint statement, "Between 2 September and 29 November, the total number of suspected yellow fever cases has reached 677, including 164 deaths," the news agency writes.

5 Dec 2012

Tissue damage, disease severity in C. diff. infection associated with disruption of PPARγ pathway

Researchers in the Nutritional Immunology and Molecular Medicine Laboratory at Virginia Bioinformatics Institute have discovered how a common diarrhea-causing bacterium sends the body's natural defenses into overdrive, actually intensifying illness while fighting infection.

1 Dec 2012

Fever News and Research

Malaria vaccine trial: an interview with Professor Sir Brian Greenwood

Study investigates different approaches to eradicate mosquito-borne diseases

Inotuzumab ozogamicin selectively destroys malignant cells responsible for ALL in weekly dosing

U.N. officials call on Security Council, international community to tackle complex crisis in Sahel

Researchers shed new light on how salmonella bacteria cause infections

Top-line results from Durata Therapeutics’ dalbavancin Phase 3 study on ABSSSI

Quizartinib shows promise against acute myeloid leukemia in Phase II trial

Celgene announces results from REVLIMID plus VIDAZA phase II study on AML

New hope for leukemia patients

New survival results from Genentech’s Perjeta Phase III combination study on HER2-positive mBC

Sanofi Pasteur’s IMOJEV vaccine against Japanese encephalitis is now available in Australia

Results of Halaven Phase III study in metastatic breast cancer presented at 2012 CTRC-AACR SABCS

Prosthetic joint infection guidelines released

Pesticides in tap water may increase food allergy risk

WHO assists Middle East authorities with coronavirus investigation

Yellow Fever kills 164 in Sudan's Darfur; Agencies working to vaccinate people in region

Tissue damage, disease severity in C. diff. infection associated with disruption of PPARγ pathway

Study of hospital-acquired infection yields potential therapeutic target

Broad range of human activities affects spread of vector-borne zoonotic diseases, experts say

DFG to establish 11 Collaborative Research Centres in Jan 2013

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News